Dr. Jung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
The Johns Hopkins Hospital
4940 Eastern Avenue
Baltimore, MD 21287- Is this information wrong?
Summary
- Dr. Moonjung Jung is a hematologist in Baltimore, MD and is affiliated with the Johns Hopkins Hospital. She received her medical degree from Ewha Womans University College of Medicine and has been in practice 10 years. She also speaks multiple languages, including Korean.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
- Methodist Hospital (Houston)Residency, Internal Medicine, 2009 - 2012
- Ewha Women's University College of MedicineClass of 2007
Certifications & Licensure
- MD State Medical License 2011 - 2024
- NY State Medical License 2016 - 2021
- DC State Medical License 2015 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Scholar Award in Basic/Translational Research ASH
- Pilot Project Award NCATS/NIH, 2016-2019
- Dean’s list College of Medicine, Ewha Womans University, 2001-2007
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsGenomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.Andrew L H Webster, Mathijs A Sanders, Krupa Patel, Ralf Dietrich, Raymond J Noonan, Francis P Lach, Ryan R White, Audrey Goldfarb, Kevin Hadi, Matthew M Edwards, Fran...> ;Nature. 2022 Dec 1
- 12 citationsMechanisms of somatic transformation in inherited bone marrow failure syndromes.Haruna Batzorig Choijilsuren, Yeji Park, Moonjung Jung> ;Hematology. American Society of Hematology. Education Program. 2021 Dec 10
- 12 citationsTranscriptional Silencing of ALDH2 Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia.Zhaolin Yang, Xiaoli S. Wu, Yiliang Wei, Sofya A. Polyanskaya, Shruti V. Iyer, Moonjung Jung, Francis P. Lach, Emmalee R. Adelman, Olaf Klingbeil, Joseph P. Milazzo, M...> ;Cancer Discovery. 2021 Apr 23
- Join now to see all
Journal Articles
- Adaptive NK cells can persist in patients with GATA2 mutation depleted of hematopoietic stem and progenitor cellsSchlums H, Jung M, Han H, Theorell J, Bigley V, Chiang SC et al, Blood, 1/1/2017
- Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ LayersHong SG, Yada RC, Choi K, Carpentier A, Liang TJ, Merling RK, Sweeney CL, Malech HL, Jung M et al, Molecular Therapy, 1/1/2017
- Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringJung M, Dunbar CE and Winkler T, Molecular Therapy, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Clinical severity correlates with in vitro residual function of FANCB missense variantsJung M, Ramanagoudr Bhojappa R, Rosti O, Lach FP, Donovan FX, Auerbach AD, et al, Fanconi Anemia Research Fund Annual Symposium, Newport Beach, CA, 1/1/2018
- The Clinical and Hematologic Course of Fanconi Anemia Amongst Affected SiblingsJung M, Rosti O, Jiang CS, Correa da Rosa J, Smogorzewska A, Boulad F, Fanconi Anemia Research Fund Annual Symposium/American Society of Hematology, the 59th Annual Meeting, Atlanta, GA, 1/1/2017
- Specific Impaired CD56+ NK Cell Development in GATA2 Deficiency As Revealed By Ex Vivo NK ExpansionAmerican Society of Hematology, the 56th Annual Meeting, San Francisco, CA, 1/1/2014
- Join now to see all
Professional Memberships
- Associate
- Member
- Member
Other Languages
- Korean
Hospital Affiliations
- Johns Hopkins Bayview Medical CenterBaltimore, Maryland
- Johns Hopkins HospitalBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: